Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' CHAMPLIN RE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 128 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. La Rosa, AM; Champlin, RE; Mirza, N; Gajewski, J; Giralt, S; Rolston, KV; Raad, I; Jacobson, K; Kontoyiannis, D; Elting, L; Whimbey, E
      Adenovirus infections in adult recipients of blood and marrow transplants

      CLINICAL INFECTIOUS DISEASES
    2. Rodriguez, J; Munsell, M; Yazji, S; Hagemeister, FB; Younes, A; Andersson, B; Giralt, S; Gajewski, J; de Lima, M; Couriel, D; Romaguera, J; Cobanillas, FF; Champlin, RE; Khouri, IF
      Impact of high-dose chemotherapy on peripheral T-cell lymphomas

      JOURNAL OF CLINICAL ONCOLOGY
    3. Ghosh, S; Champlin, RE; Ueno, NT; Anderlini, P; Rolston, K; Raad, I; Kontoyiannis, D; Jacobson, K; Luna, M; Tarrand, J; Whimbey, E
      Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins

      BONE MARROW TRANSPLANTATION
    4. Konoplev, S; Champlin, RE; Giralt, S; Ueno, NT; Khouri, I; Raad, I; Rolston, K; Jacobson, K; Tarrand, J; Luna, M; Nguyen, Q; Whimbey, E
      Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients

      BONE MARROW TRANSPLANTATION
    5. Anderlini, P; Rizzo, JD; Nugent, ML; Schmitz, N; Champlin, RE; Horowitz, MM
      Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases

      BONE MARROW TRANSPLANTATION
    6. Donato, ML; Gershenson, DM; Wharton, JT; Ippoliti, CM; Aleman, AS; Bodurka-Bevers, D; Bevers, MW; Burke, TW; Levenback, CF; Wolf, JK; Freedman, RS; Bast, RC; Gajewski, JL; Champlin, RE
      High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: A new regimen for the treatment of advanced ovarian cancer

      GYNECOLOGIC ONCOLOGY
    7. Gopal, R; Ha, CS; Tucker, SL; Khouri, IF; Giralt, SA; Gajewski, JL; Andersson, BS; Cox, JD; Champlin, RE
      Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity

      CANCER
    8. Khouri, IF; Saliba, RM; Giralt, SA; Lee, MS; Okoroji, GJ; Hagemeister, FB; Korbling, M; Younes, A; Ippoliti, C; Gajewski, JL; McLaughlin, P; Anderlini, P; Donato, ML; Cabanillas, FF; Champlin, RE
      Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

      BLOOD
    9. Ueno, NT; Champlin, RE
      High-dose chemotherapy as treatment for high-risk primary and metastatic breast cancer

      BREAST CANCER
    10. Andersson, BS; Madden, T; Tran, HT; Hu, WW; Blume, KG; Chow, DSL; Champlin, RE; Vaughan, WP
      Acute safety and pharmacokinetics of intravenous busulfan when used with oval busulfan and cyclophosphamide as pretransplantation conditioning therapy: A phase I study

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    11. Nieto, Y; Champlin, RE; Wingard, JR; Vredenburgh, JJ; Elias, AD; Richardson, PR; Glaspy, J; Jones, RB; Stiff, PJ; Bearman, SI; Cagnoni, PJ; McSweeney, PA; LeMaistre, CF; Pecora, AL; Shpall, EJ
      Status of high-dose chemotherapy for breast cancer: A review

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    12. Molldrem, JJ; Lee, PP; Wang, CQ; Felio, K; Kantarjian, HM; Champlin, RE; Davis, MM
      Evidence that specific T lymphocytes may participate in the elimination ofchronic myelogenous leukemia

      NATURE MEDICINE
    13. Couriel, DR; Hicks, K; Giralt, S; Champlin, RE
      Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation

      CURRENT OPINION IN ONCOLOGY
    14. Kornblau, S; Benson, AB; Catalano, R; Champlin, RE; Engelking, C; Field, M; Ippoliti, C; Lazarus, HM; Mitchell, E; Rubin, J; Stiff, PJ; Vokes, E; Wadler, S
      Management of cancer treatment-related diarrhea: Issues and therapeutic strategies

      JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
    15. Seong, CM; Giralt, S; Kantarjian, H; Xu, JP; Swantkowski, J; Hayes, K; Glassman, AB; Khouri, I; Korbling, M; Thall, P; Siciliano, MJ; Champlin, RE
      Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    16. Donato, ML; Champlin, RE; Wharton, JT; Bodurka-Bevers, D; Gershenson, D
      Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    17. Buchholz, TA; Tucker, SL; Moore, RA; McNeese, MD; Strom, EA; Jhingrin, A; Hortobagyi, GN; Singletary, SE; Champlin, RE
      Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    18. Anderlini, P; Giralt, S; Andersson, B; Ueno, NT; Khouri, I; Acholonu, S; Cohen, A; Korbling, MJ; Manning, J; Romaguera, J; Sarris, A; Rodriguez, MA; Hagemeister, F; McLaughlin, P; Cabanillas, F; Champlin, RE
      Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease

      BONE MARROW TRANSPLANTATION
    19. Huaringa, AJ; Leyva, FJ; Signes-Costa, J; Morice, RC; Raad, I; Darwish, AA; Champlin, RE
      Bronchoalveolar lavage in the diagnosis of pulmonary complications of bonemarrow transplant patients

      BONE MARROW TRANSPLANTATION
    20. Ghosh, S; Champlin, RE; Englund, J; Giralt, SA; Rolston, K; Raad, I; Jacobson, K; Neumann, J; Ippoliti, C; Mallik, S; Whimbey, E
      Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

      BONE MARROW TRANSPLANTATION
    21. Donato, ML; Gershenson, D; Ippoliti, C; Wharton, JT; Bast, RC; Aleman, A; Anderlini, P; Gajewski, JG; Giralt, S; Molldrem, J; Ueno, N; Lauppe, J; Korbling, M; Boyer, J; Bodurka-Bevers, D; Bevers, M; Burke, T; Freedman, R; Levenback, C; Wolf, J; Champlin, RE
      High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer

      BONE MARROW TRANSPLANTATION
    22. Andersson, BS; Gajewski, J; Donato, M; Giralt, S; Gian, V; Wingard, J; Tarantolo, S; Fernandez, H; Hu, WW; Blume, K; Kashyap, A; Forman, SJ; Champlin, RE
      Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)

      BONE MARROW TRANSPLANTATION
    23. Huaringa, AJ; Leyva, FJ; Giralt, SA; Blanco, J; Signes-Costa, J; Velarde, H; Champlin, RE
      Outcome of bone marrow transplantation patients requiring mechanical ventilation

      CRITICAL CARE MEDICINE
    24. Rodriguez, J; Keating, MJ; O'Brien, S; Champlin, RE; Khouri, IF
      Allogeneic haematopoietic transplantation for Richter's syndrome

      BRITISH JOURNAL OF HAEMATOLOGY
    25. Champlin, RE; Schmitz, N; Horowitz, MM; Chapuis, B; Chopra, R; Cornelissen, JJ; Gale, RP; Goldman, JM; Loberiza, FR; Hertenstein, B; Klein, JP; Montserrat, E; Zhang, MJ; Ringden, O; Tomany, SC; Rowlings, PA; Van Hoef, MEHM; Gratwohl, A
      Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation

      BLOOD
    26. Champlin, RE; Passweg, JR; Zhang, MJ; Rowlings, PA; Pelz, CJ; Atkinson, KA; Barrett, AJ; Cahn, JY; Drobyski, WR; Gale, RP; Goldman, JM; Gratwohl, A; Gordon-Smith, EC; Henslee-Downey, PJ; Herzig, RH; Klein, JP; Marmont, AM; O'Reilly, RJ; Ringden, O; Slavin, S; Sobocinski, KA; Speck, B; Weiner, RS; Horowitz, MM
      T-cell depletion of bone marrow transplants for leukemia from donors otherthan HLA-identical siblings: advantage of T-cell antibodies with narrow specificities

      BLOOD
    27. Hortobagyi, GN; Buzdar, AU; Theriault, RL; Valero, V; Frye, D; Booser, DJ; Holmes, FA; Giralt, S; Khouri, I; Andersson, B; Gajewski, JL; Rondon, G; Smith, TL; Singletary, SE; Ames, FC; Sneige, N; Strom, EA; McNeese, MD; Deisseroth, AB; Champlin, RE
      Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    28. Champlin, RE
      Innovative approaches for allogeneic blood and marrow transplantation for treatment of hematological malignancies - Graft engineering and nonmyeloablative preparative regimens

      HEMATOPOIETIC STEM CELL TRANSPLANTION
    29. Giralt, SA; Champlin, RE
      T-cell subsets and separation of GVL from GVHD

      ALLOGENEIC IMMUNOTHERAPY FOR MALIGNANT DISEASES
    30. Donato, ML; Champlin, RE; Van Besien, KW; Korbling, M; Cabanillas, F; Anderlini, P; Gajewski, JG; Lauppe, J; Durett, A; Andersson, B; Giralt, S; Khouri, I; Hagemeister, F; Romaguera, JE; Sarris, A; McLaughlin, P; Younes, A; Ippoliti, C; Blamble, DA; Hester, J; Gee, A; Rodriguez, MA
      Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma

      LEUKEMIA & LYMPHOMA
    31. Garderet, L; Snell, V; Przepiorka, D; Schenk, T; Lu, JG; Marini, F; Gluckman, E; Andreeff, M; Champlin, RE
      Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations

      TRANSPLANTATION
    32. Anderlini, P; Donato, M; Chan, KW; Huh, YO; Gee, AP; Lauppe, MJ; Champlin, RE; Korbling, M
      Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience

      TRANSFUSION
    33. Molldrem, JJ; Lee, PP; Wang, CQ; Champlin, RE; Davis, MM
      A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia

      CANCER RESEARCH
    34. Choudhury, A; Liang, JC; Thomas, EK; Flores-Romo, L; Xie, QS; Agusala, K; Sutaria, S; Sinha, I; Champlin, RE; Claxton, DF
      Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses

      BLOOD
    35. ENGLUND JA; CHAMPLIN RE; WYDE PR; KANTARJIAN H; ATMAR RL; TARRAND J; YOUSUF H; REGNERY H; KLIMOV AI; COX NJ; WHIMBEY E
      COMMON EMERGENCE OF AMANTADINE-RESISTANT AND RIMANTADINE-RESISTANT INFLUENZA-A VIRUSES IN SYMPTOMATIC IMMUNOCOMPROMISED ADULTS

      Clinical infectious diseases
    36. CHOUDHURY A; TOUBERT A; SUTARIA S; CHARRON D; CHAMPLIN RE; CLAXTON DF
      HUMAN LEUKEMIA-DERIVED DENDRITIC CELLS - EX-VIVO DEVELOPMENT OF SPECIFIC ANTILEUKEMIC CYTOTOXICITY

      Critical reviews in immunology
    37. RAYMOND E; SHARMA S; SUN D; CHAMPLIN RE; SODA H; BOLDT DH; VONHOFF DD
      SENSITIVITY AND SPECIFICITY OF TELOMERASE TO DETECT CANCER-CELLS IN ROUTINE HUMAN BIOPSIES

      Annals of oncology
    38. BOJKO P; HESTER JP; DURETT AG; MAADANI F; KORBLING M; CHAMPLIN RE
      IDENTIFICATION OF MEGAKARYOCYTE PRECURSORS IN PERIPHERAL-BLOOD STEM-CELL COLLECTIONS FROM NORMAL DONORS

      Journal of clinical apheresis
    39. UENO NT; RONDON G; MIRZA NQ; GEISLER DK; ANDERLINI P; GIRALT SA; ANDERSSON BS; CLAXTON DF; GAJEWSKI JL; KHOURI IF; KORBLING M; MEHRA RC; PRZEPIORKA D; RAHMAN Z; SAMUELS BI; VANBESIEN K; HORTOBAGYI GN; CHAMPLIN RE
      ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR POOR-RISK PATIENTS WITH METASTATIC BREAST-CANCER

      Journal of clinical oncology
    40. ANDERSSON BS; MARTINKA S; MCWILLIAMS K; HAI T; MOLLDREM J; BRUTON J; GIAN V; FERNANDEZ H; TARANTOLO S; KASHYAP A; FORMAN SJ; HU W; BLUME K; CAGNONI P; JONES R; CHAMPLIN RE
      THERAPY WITH IV BUSULFAN, CYTOXAN (BUCY) AND ALLOGENEIC HEMATOPOIETICSTEM-CELLS (HSC) FOR ADVANCED HEMATOLOGICAL MALIGNANCIES

      Bone marrow transplantation
    41. MCCULLOUGH SP; WENDT RE; MACEY DJ; CHAMPLIN RE; SIMON J; PODOLOFF DA
      NONTARGET ORGAN DOSES IN PATIENTS UNDERGOING BONE-MARROW ABLATION WITH HO-166-DOTMP

      The Journal of nuclear medicine
    42. SHPALL EJ; CHAMPLIN RE; EAVES AC; GEE AP; COLLINS N; LEMAISTRE CF; OREILLY R; ROWLEY SD; SULLIVAN K; VAUGHAN WP; WARKENTIN PL
      FOUNDATION FOR THE ACCREDITATION OF HEMATOPOIETIC-CELL THERAPY (FAHCT) RESPONSE TO FDA (DOCKET NO.97N-0068)

      Journal of hematotherapy
    43. JOHANSEN MJ; MADDEN T; MEHRA RC; WOOD JG; RONDON G; BROWNE V; NEWMAN RA; CHAMPLIN RE
      PHASE-I PHARMACOKINETIC STUDY OF MULTICYCLE HIGH-DOSE CARBOPLATIN FOLLOWED BY PERIPHERAL-BLOOD STEM-CELL INFUSION IN PATIENTS WITH CANCER

      Journal of clinical oncology
    44. RAHMAN ZU; FRYE DK; BUZDAR AU; SMITH TL; ASMAR L; CHAMPLIN RE; HORTOBAGYI GN
      IMPACT OF SELECTION PROCESS ON RESPONSE RATE AND LONG-TERM SURVIVAL OF POTENTIAL HIGH-DOSE CHEMOTHERAPY CANDIDATES TREATED WITH STANDARD-DOSE DOXORUBICIN-CONTAINING CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER

      Journal of clinical oncology
    45. DELIMA M; VANBESIEN KW; GIRALT SA; KHOURI IF; MEHRA R; ANDERSSON BS; PRZEPIORKA D; GAJEWSKI JL; KORBLING M; CHAMPLIN RE
      BONE-MARROW TRANSPLANTATION AFTER FAILURE OF AUTOLOGOUS TRANSPLANT FOR NON-HODGKINS-LYMPHOMA

      Bone marrow transplantation
    46. VANBESIEN KW; DELIMA M; GIRALT SA; MOORE DF; KHOURI IF; RONDON G; MEHRA R; ANDERSSON BS; DYER C; CLEARY K; PRZEPIORKA D; GAJEWSKI JL; CHAMPLIN RE
      MANAGEMENT OF LYMPHOMA RECURRENCE AFTER ALLOGENEIC TRANSPLANTATION - THE RELEVANCE OF GRAFT-VERSUS-LYMPHOMA EFFECT

      Bone marrow transplantation
    47. ZHANG MJ; BACCARANI M; GALE RP; MCGLAVE PB; ATKINSON K; CHAMPLIN RE; DICKE KA; GIRALT S; GLUCKMAN E; GOLDMAN JM; KLEIN JP; HERZIG RH; MASAOKA T; OREILLY RJ; ROZMAN C; ROWLINGS PA; SOBOCINSKI KA; SPECK B; ZWAAN FE; HOROWITZ MM
      SURVIVAL OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA RELAPSING AFTER BONE-MARROW TRANSPLANTATION - COMPARISON WITH PATIENTS RECEIVING CONVENTIONAL CHEMOTHERAPY

      British Journal of Haematology
    48. KHOURI IF; PRZEPIORKA D; VANBESIEN K; OBRIEN S; PALMER JL; LERNER S; MEHRA RC; VRIESENDORP HM; ANDERSSON BS; GIRALT S; KORBLING M; KEATING MJ; CHAMPLIN RE
      ALLOGENEIC BLOOD OR MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - TIMING OF TRANSPLANTATION AND POTENTIAL EFFECT OF FLUDARABINEON ACUTE GRAFT-VERSUS-HOST DISEASE

      British Journal of Haematology
    49. PASSWEG JR; SOCIE G; HINTERBERGER W; BACIGALUPO A; BIGGS JC; CAMITTA BM; CHAMPLIN RE; GALE RP; GLUCKMAN E; GORDONSMITH EC; HOWS JM; KLEIN JP; NUGENT ML; PASQUINI R; ROWLINGS PA; SPECK B; TICHELLI A; ZHANG MJ; HOROWITZ MM; BORTIN MM
      BONE-MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA - HAS OUTCOME IMPROVED

      Blood
    50. POPAT U; ANDERSSON BS; VANBESIEN K; SMITH T; AMIN K; HUGHES P; FAHMI H; GIRALT S; MEHRA R; PRZEPIORKA D; KHOURI I; GAJEWSKI J; CLAXTON D; RODRIGUEZ M; ROMAGUERA J; HAGEMEISTER F; CABANILLAS F; CHAMPLIN RE
      ABMT IN RECURRENT OR REFRACTORY HD - LONG-TERM RESULTS

      Blood
    51. ANDERSSON BS; HAI T; MADDEN T; CAGNONI P; JONES R; BRUTON J; MARTINKA S; HOLBERT K; GIRALT S; PRZEPIORKA D; LENNON S; SPILKER B; GIAN V; WINGARD J; TARANTOLO S; KASHYAP A; FORMAN S; CHAMPLIN RE
      ALLOGENEIC TRANSPLANTATION IN ADVANCED HEMATOLOGIC MALIGNANCIES AFTER-IV BUSULFAN CYCLOFOSFAMIDE (BUCY)

      Blood
    52. CHOUDHURY A; GAJEWSKI JL; LIANG JC; POPAT U; CLAXTON DF; KLICHE KO; ANDREEFF M; CHAMPLIN RE
      USE OF LEUKEMIC DENDRITIC CELLS FOR THE GENERATION OF ANTILEUKEMIC CELLULAR CYTOTOXICITY AGAINST PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA

      Blood
    53. WHIMBEY E; CHAMPLIN RE; COUCH RB; ENGLUND JA; GOODRICH JM; RAAD I; PRZEPIORKA D; LEWIS VA; MIRZA N; YOUSUF H; TARRAND JJ; BODEY GP
      COMMUNITY RESPIRATORY VIRUS-INFECTIONS AMONG HOSPITALIZED ADULT BONE-MARROW TRANSPLANT RECIPIENTS

      Clinical infectious diseases
    54. GALE RP; BUCHNER T; ZHANG MJ; HEINECKE A; CHAMPLIN RE; DICKE KA; GLUCKMAN E; GOOD RA; GRATWOHL A; HERZIG RH; KEATING A; KLEIN JP; MARMONT AM; PRENTICE HG; ROWLINGS PA; SOBOCINSKI KA; SPECK B; WEINER RS; HOROWITZ MM
      HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTS VS CHEMOTHERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN FIRST REMISSION

      Leukemia
    55. GALE RP; HOROWITZ MM; REES JKH; GRAY RG; OKEN MM; ESTEY EH; KIM KM; ZHANG MJ; ASH RC; ATKINSON K; CHAMPLIN RE; DICKE KA; GAJEWSKI JL; GOLDMAN JM; HELBIG W; HENSLEEDOWNEY PJ; HINTERBERGER W; JACOBSEN N; KEATING A; KLEIN JP; MARMONT AM; PRENTICE HG; REIFFERS J; RIMM AA; ROWLINGS PA; SOBOCINSKI KA; SPECK B; WINGARD JR; BORTIN MM
      CHEMOTHERAPY VERSUS TRANSPLANTS FOR ACUTE MYELOGENOUS LEUKEMIA IN 2NDREMISSION

      Leukemia
    56. GAJEWSKI JL; PHILLIPS GL; SOBOCINSKI KA; ARMITAGE JO; GALE RP; CHAMPLIN RE; HERZIG RH; HURD DD; JAGANNATH S; KLEIN JP; LAZARUS HM; MCCARTHY PL; PAVLOVSKY S; PETERSEN FB; ROWLINGS PA; RUSSELL JA; SILVER SM; VOSE JM; WIERNIK PH; BORTIN MM; HOROWITZ MM
      BONE-MARROW TRANSPLANTS FROM HLA-IDENTICAL SIBLINGS IN ADVANCED HODGKINS-DISEASE

      Journal of clinical oncology
    57. KHOURI IF; IPPOLITI C; GAJEWSKI J; PRZEPIORKA D; CHAMPLIN RE
      NEUTROPENIAS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - RESPONSE TO THERAPY WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN

      American journal of hematology
    58. KHOURI IF; KANTARJIAN HM; TALPAZ M; GIRALT S; RIOS MO; HESTER JP; CHAMPLIN RE; DEISSEROTH AB
      RESULTS WITH HIGH-DOSE CHEMOTHERAPY AND UNPURGED AUTOLOGOUS STEM-CELLTRANSPLANTATION IN 73 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA - THE MD ANDERSON EXPERIENCE

      Bone marrow transplantation
    59. ROZMAN C; CARRERAS E; QIAN C; GALE RP; BORTIN MM; ROWLINGS PA; ASH RC; CHAMPLIN RE; HENSLEEDOWNEY PJ; HERZIG RH; HINTERBERGER W; KLEIN JP; PRENTICE HG; REIFFERS J; ZWAAN FE; HOROWITZ MM
      RISK-FACTORS FOR HEPATIC VENOOCCLUSIVE DISEASE FOLLOWING HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTS FOR LEUKEMIA

      Bone marrow transplantation
    60. PODOLOFF DA; MACEY DJ; CHAMPLIN RE
      UPDATE ON THE HO-166 DOTMP BONE-MARROW ABLATION TRIAL AT UTMD ANDERSON-CANCER-CENTER

      The Journal of nuclear medicine
    61. CHAMPLIN RE; FIGLIN RA
      EVOLVING CLINICAL-APPLICATIONS OF HEMATOPOIETIC GROWTH-FACTORS - INTRODUCTION

      Seminars in oncology
    62. CHAMPLIN RE
      PERIPHERAL-BLOOD PROGENITOR CELLS - A REPLACEMENT FOR MARROW TRANSPLANTATION

      Seminars in oncology
    63. ANDERSSON BS; MADDEN T; STANFIELD L; HU W; CHOW DSL; BLUME K; WILLIAMS TE; VAUGHAN WP; CHAMPLIN RE
      PRETRANSPLANTATION CONDITIONING THERAPY WITH IV BUSULFAN CYCLOPHOSPHAMIDE (BUCY) - A PHASE-I STUDY/

      Blood
    64. UENO NT; RONDON G; GEISLER D; GIRALT S; MEHRA R; PRZEPIORKA D; ANDERSSON B; GAJEWSKI J; KHOURI I; KORBLING M; SEONG D; RAHMAN Z; VANBESIEN K; ANDERLINI P; HORTOBAGYI G; CHAMPLIN RE
      ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION FOR INDUCTION OF GRAFT VERSUS TUMOR EFFECT IN PATIENTS WITH METASTATIC BREAST-CANCER

      Blood
    65. SEONG D; GIRALT S; KANTARJIAN H; XU JP; SWANTKOWSKI J; HAYES K; GLASSMAN AB; ALBITAR M; KHOURI I; KORBLING M; SICILIANO MJ; CHAMPLIN RE
      EARLY DETECTION OF RELAPSE BY HYPERMETAPHASE FISH AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA

      Blood
    66. VANBESIEN KW; KHOURI IF; GIRALT SA; MCCARTHY P; MEHRA R; ANDERSSON BS; PRZEPIORKA D; GAJEWSKI JL; BELLARE N; NATH R; ROMAGUERA JE; MCLAUGHLIN P; KORBLING M; DEISSEROTH AB; CABANILLAS FF; CHAMPLIN RE
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE LYMPHOMA - THE CASE FOR AGGRESSIVE MANAGEMENT

      Journal of clinical oncology
    67. HOROWITZ; LEBKOWSKI J; SOUZA S; TRICOT G; OREILLY RJ; CHAMPLIN RE; OKARMA T
      SELECTIVE CD5 CD8 T-CELL SUBSET DEPLETION OF DONOR BONE-MARROW IN HLA-IDENTICAL SIBLING TRANSPLANTS COMPARED WITH A/

      Experimental hematology
    68. PRZEPIORKA D; CHAN KW; CHAMPLIN RE; CULBERT SJ; PETROPOULOS D; IPPOLITI C; KHOURI I; HUH YO; VREISENDORP H; DEISSEROTH AB; BLEYER WA
      PREVENTION OF GRAFT-VERSUS-HOST-DISEASE WITH ANTI-CD5 RICIN-A CHAIN IMMUNOTOXIN AFTER CD3-DEPLETED HLA-NONIDENTICAL MARROW TRANSPLANTATION IN PEDIATRIC LEUKEMIA PATIENTS

      Bone marrow transplantation
    69. WHIMBEY E; CHAMPLIN RE; ENGLUND JA; MIRZA NQ; PIEDRA PA; GOODRICH JM; PRZEPIORKA D; LUNA MA; MORICE RC; NEUMANN JL; ELTING LS; BODEY GP
      COMBINATION THERAPY WITH AEROSOLIZED RIBAVIRIN AND INTRAVENOUS IMMUNOGLOBULIN FOR RESPIRATORY SYNCYTIAL VIRUS-DISEASE IN ADULT BONE-MARROW TRANSPLANT RECIPIENTS

      Bone marrow transplantation
    70. VANBESIEN K; TABOCOFF J; RODRIGUEZ M; ANDERSSON B; MEHRA R; PRZEPIORKA D; DIMOPOULOS M; GIRALT S; SUKI S; KHOURI I; SPITZER G; JAGANNATH S; DICKE K; LEMAISTRE CF; DEISSEROTH A; CABANILLAS F; CHAMPLIN RE
      HIGH-DOSE CHEMOTHERAPY WITH BEAC REGIMEN AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR INTERMEDIATE GRADE AND IMMUNOBLASTIC LYMPHOMA - DURABLE COMPLETE REMISSIONS, BUT A HIGH-RATE OF REGIMEN-RELATED TOXICITY

      Bone marrow transplantation
    71. BAYOUTH JE; MACEY DJ; KASI LP; GARLICH JR; MCMILLAN K; DIMOPOULOS MA; CHAMPLIN RE
      PHARMACOKINETICS, DOSIMETRY AND TOXICITY OF HOLMIUM-166-DOTMP FOR BONE-MARROW ABLATION IN MULTIPLE-MYELOMA

      The Journal of nuclear medicine
    72. BAYOUTH JE; MACEY DJ; BOYER AL; CHAMPLIN RE
      RADIATION-DOSE DISTRIBUTION WITHIN THE BONE-MARROW OF PATIENTS RECEIVING HOLMIUM-166-LABELED-PHOSPHONATE FOR MARROW ABLATION

      Medical physics
    73. KORBLING M; HUH YO; DURETT A; MIRZA N; MILLER P; ENGEL H; ANDERLINI P; VANBESIEN K; ANDREEFF M; PRZEPIORKA D; DEISSEROTH AB; CHAMPLIN RE
      ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION - PERIPHERALIZATION AND YIELD OF DONOR-DERIVED PRIMITIVE HEMATOPOIETIC PROGENITOR CELLS (CD34(-1(DIM)) AND LYMPHOID SUBSETS, AND POSSIBLE PREDICTORS OF ENGRAFTMENT AND GRAFT-VERSUS-HOST DISEASE() THY)

      Blood
    74. GLUCKMAN E; AUERBACH AD; HOROWITZ MM; SOBOCINSKI KA; ASH RC; BORTIN MM; BUTTURINI A; CAMITTA BM; CHAMPLIN RE; FRIEDRICH W; GOOD RA; GORDONSMITH EC; HARRIS RE; KLEIN JP; ORTEGA JJ; PASQUINI R; RAMSAY NKC; SPECK B; VOWELS MR; ZHANG MJ; GALE RP
      BONE-MARROW TRANSPLANTATION FOR FANCONI-ANEMIA

      Blood
    75. SEONG DC; KANTARJIAN HM; RO JY; TALPAZ M; XU JP; ROBINSON JR; DEISSEROTH AB; CHAMPLIN RE; SICILIANO MJ
      HYPERMETAPHASE FLUORESCENCE IN-SITU HYBRIDIZATION FOR QUANTITATIVE MONITORING OF PHILADELPHIA-CHROMOSOME-POSITIVE CELLS IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA DURING TREATMENT

      Blood
    76. KORBLING P; PRZEPIORKA D; GAJEWSKI J; CHAMPLIN RE; CHAN KW
      WITH FIRST SUCCESSFUL ALLOGENEIC TRANSPLANTATIONS OF APHERESIS-DERIVED HEMATOPOIETIC PROGENITOR CELLS REPORTED, CAN THE RECRUITMENT OF VOLUNTEER MATCHED, UNRELATED STEM-CELL DONORS BE EXPANDED SUBSTANTIALLY

      Blood
    77. BOJKO P; HESTER JP; DURETT AG; KORBLING M; CHAMPLIN RE
      IDENTIFICATION OF MEGAKARYOCYTE (MK) PRECURSORS IN PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTIONS OF NORMAL DONORS

      Blood
    78. ANDERSSON BS; MADDEN T; HU W; CHOW D; VAUGHN WP; BLUME K; WILLIAMS TE; CHAMPLIN RE
      PHASE ONE STUDY OF INTRAVENOUS (IV) BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) AS PRETRANSPLANTATION CONDITIONING THERAPY

      Blood
    79. KHOURI I; KEATING MJ; PRZEPIORKA D; VANBESIEN K; GAJEWSKI J; OBRIEN S; HUH YO; MEHRA R; GIRALT S; SEONG D; KORBLING M; DEISSEROTH AB; CHAMPLIN RE
      STEM-CELL TRANSPLANTATION (SCT) FOR CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - GRAFT-VERSUS-LEUKEMIA (GVL) WITHOUT ACUTE GRAFT-VERSUS-HOST-DISEASE (GVHD)

      Blood
    80. PAQUETTE RL; TEBYANI N; FRANE M; IRELAND P; HO WG; CHAMPLIN RE; NIMER SD
      LONG-TERM OUTCOME OF APLASTIC-ANEMIA IN ADULTS TREATED WITH ANTITHYMOCYTE GLOBULIN - COMPARISON WITH BONE-MARROW TRANSPLANTATION

      Blood
    81. ABUFARSAKH HAA; KATZ RL; ATKINSON N; CHAMPLIN RE
      PROGNOSTIC FACTORS IN BRONCHOALVEOLAR LAVAGE IN 77 PATIENTS WITH BONE-MARROW TRANSPLANTS

      Acta cytologica
    82. SCERPELLA EG; WHIMBEY EE; CHAMPLIN RE; BODEY GP
      PERICARDITIS ASSOCIATED WITH LEGIONNAIRES-DISEASE IN A BONE-MARROW TRANSPLANT RECIPIENT

      Clinical infectious diseases
    83. PRZEPIORKA D; DIMOPOULOS M; SMITH T; IPPOLITI C; DIENER K; LUNA M; CHAMPLIN RE
      THIOTEPA, BUSULFAN, AND CYCLOPHOSPHAMIDE AS A PREPARATIVE REGIMEN FORMARROW TRANSPLANTATION - RISK-FACTORS FOR EARLY REGIMEN-RELATED TOXICITY

      Annals of hematology
    84. GIRALT SA; LEMAISTRE CF; VRIESENDORP HM; ANDERSSON BS; DIMOPOULOS M; GAJEWSKI J; VANBESIEN K; MEHRA R; PRZEPIORKA D; KHOURI I; YAU J; KANTARJIAN H; DEISSEROTH AB; CHAMPLIN RE
      ETOPOSIDE, CYCLOPHOSPHAMIDE, TOTAL-BODY IRRADIATION, AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES

      Journal of clinical oncology
    85. KHOURI IF; KEATING MJ; VRIESENDORP HM; READING CL; PRZEPIORKA D; HUH YO; ANDERSSON BS; VANBESIEN KW; MEHRA RC; GIRALT SA; IPPOLITI C; MARSHALL M; THOMAS MW; OBRIEN S; ROBERTSON LE; DEISSEROTH AB; CHAMPLIN RE
      AUTOLOGOUS AND ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS

      Journal of clinical oncology
    86. MEYERS CA; WEITZNER M; BYRNE K; VALENTINE A; CHAMPLIN RE; PRZEPIORKA D
      EVALUATION OF THE NEUROBEHAVIORAL FUNCTIONING OF PATIENTS BEFORE, DURING, AND AFTER BONE-MARROW TRANSPLANTATION

      Journal of clinical oncology
    87. KOBERDA J; PRZEPIORKA D; BEDNARCZYK J; ESCUDIER S; CHAMPLIN RE; DEISSEROTH AB; MCINTYRE BW
      IDENTIFICATION OF HYPERGLYCOSYLATED E-SELECTING (ELAM-1) EXPRESSION ON NORMAL AND LEUKEMIC HEMATOPOIETIC-CELLS

      Experimental hematology
    88. SEYMOUR JF; KHOURI IF; CHAMPLIN RE; KEATING MJ
      REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA COMPLICATED BY HYPERCALCEMIA TREATED WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION - CASE-REPORT AND REVIEW

      American journal of clinical oncology
    89. VRIESENDORP HM; CHU H; OCHRAN TG; BESA PC; CHAMPLIN RE
      RADIOBIOLOGY OF TOTAL-BODY RADIATION

      Bone marrow transplantation
    90. KORBLING M; DRACH J; CHAMPLIN RE; ENGEL H; HUYNH L; KLEINE HD; BERENSON R; DEISSEROTH AB; ANDREEFF M
      LARGE-SCALE PREPARATION OF HIGHLY PURIFIED, FROZEN THAWED CD34(+), HLA-DR(-) HEMATOPOIETIC PROGENITOR CELLS BY SEQUENTIAL IMMUNOADSORPTION (CEPRATE SC) AND FLUORESCENCE-ACTIVATED CELL SORTING - IMPLICATIONS FOR GENE TRANSDUCTION AND/OR TRANSPLANTATION/

      Bone marrow transplantation
    91. WHIMBEY E; ELTING LS; COUCH RB; LO W; WILLIAMS L; CHAMPLIN RE; BODEY GP
      INFLUENZA-A VIRUS-INFECTIONS AMONG HOSPITALIZED ADULT BONE-MARROW TRANSPLANT RECIPIENTS

      Bone marrow transplantation
    92. PRZEPIORKA D; IPPOLITI C; PANINA A; GOODRICH J; GIRALT S; VANBESIEN K; MEHRA R; DEISSEROTH AB; ANDERSSON B; LUNA M; TARRAND JJ; CHAMPLIN RE
      GANCICLOVIR 3 TIMES PER WEEK IS NOT ADEQUATE TO PREVENT CYTOMEGALOVIRUS REACTIVATION AFTER T-CELL-DEPLETED MARROW TRANSPLANTATION

      Bone marrow transplantation
    93. STOREK J; HULTIN LE; FERRARA S; KU N; GIORGI JV; CHAMPLIN RE; SAXON A
      B-CELL DYSFUNCTION AFTER BONE-MARROW TRANSPLANTATION IS ASSOCIATED WITH DECREASED CA2-LINKING( FLUX UPON MEMBRANE IG CROSS)

      Clinical immunology and immunopathology
    94. PRZEPIORKA D; IPPOLITI C; KOBERDA J; CHAN KW; KHOURI IF; FISCHER HE; HUH YO; ESCUDIER SM; SEONG D; DAVIS M; GAJEWSKI J; VRIESENDORP HM; CHAMPLIN RE
      INTERLEUKIN-2 FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER HAPLOIDENTICAL MARROW TRANSPLANTATION

      Transplantation
    95. NIMER SD; GIORGI J; GAJEWSKI JL; KU N; SCHILLER GJ; LEE K; TERRITO M; HO W; FEIG S; SELCH M; ISACESCU V; REICHERT TA; CHAMPLIN RE
      SELECTIVE DEPLETION OF CD8(-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION - A RANDOMIZED CONTROLLED TRIAL() CELLS FOR PREVENTION OFGRAFT)

      Transplantation
    96. GIRALT SA; CHAMPLIN RE
      LEUKEMIA RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REVIEW

      Blood
    97. VANBESIEN KW; KHOURI IF; GIRALT SA; MCCARTHY P; MEHRA R; ANDERSSON BS; PRZEPIORKA D; GAJEWSKI JL; BELLARE N; NATH R; ROMAGUERA JE; MCLAUGHLIN PW; KORBLING M; DEISSEROTH AB; CABANILLAS FF; CHAMPLIN RE
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR REFRACTORY AND RECURRENT LOW-GRADE LYMPHOMA - THE CASE FOR AGGRESSIVE MANAGEMENT

      Blood
    98. KHOURI IF; SUKI S; VANBESIEN K; MCLAUGHLIN P; VRIESENDORP H; PRZEPIORKA D; ANDERSSON B; GIRALT S; GAJEWSKI J; MEHRA R; CABANILLAS F; DEISSEROTH AB; CHAMPLIN RE
      ETOPOSIDE, CYCLOPHOSPHAMIDE (CY), TOTAL-BODY IRRADIATION (TBI), AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR LOW-GRADE NON-HODGKINS-LYMPHOMA (LGL)

      Blood
    99. CHAMPLIN RE; MEHRA R; KAYE JA; WOODIN MB; GEISLER D; DAVIS M; WOOD J; ANDERSSON B; VANBESIEN K; GAJEWSKI J; PRZEPIORKA D; DEISSEROTH AB
      RECOMBINANT HUMAN INTERLEUKIN-11 (RHIL-11) FOLLOWING AUTOLOGOUS BMT FOR BREAST-CANCER

      Blood
    100. RUMMEL SA; CHAMPLIN RE; BRADLEY MS; LARSON DB; OGIER W; VANZANT G
      EVALUATION OF CHRONIC LYMPHOCYTIC-LEUKEMIA CELL-SURVIVAL DURING CULTURE IN A CELL EXPANSION SYSTEM

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 16:36:19